Key result
Class IA, IC, and III antiarrhythmic medications effectively convert supraventricular arrhythmias to sinus rhythm, with conversion rates frequently greater than 50%.
Why the study?
Are antiarrhythmic medications effective and safe for pharmacologic cardioversion in patients with cardiac arrhythmias?
Are antiarrhythmic medications effective and safe for pharmacologic cardioversion in patients with cardiac arrhythmias?
Pharmacologic cardioversion with antiarrhythmic medications is an effective alternative to electrical cardioversion for supraventricular and ventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
May support pharmacologic cardioversion as an alternative in select patients; leaves open randomized safety and comparative efficacy data.
Introduction: Cardiac arrhythmias, including supraventricular and ventricular tachycardias, portend a higher risk of morbidity and mortality.These arrhythmias also are associated with increased healthcare resource utilization, decreased quality of life, and increased activity impairment.Pharmacologic conversion is a treatment option for conversion to sinus rhythm that has the advantage of avoiding sedation from DC cardioversion.Objective: To review the efficacy, side effects, clearance, and prescribing considerations for antiarrhythmic medications for pharmacologic cardioversion. Methodology:We included studies evaluating the efficacy of antiarrhythmic drugs.We included prescribing indications including half-life, clearance, and side effects.We arranged the manuscript by Vaughan Williams classification.Results: Class IA, class IC, and class III antiarrhythmic medications are effective at conversion of supraventricular arrhythmias with rates frequently greater than 50%.Amiodarone and Lidocaine may be used for conversion of ventricular tachycardias.The specific agent utilized depends upon the potential other medication interactions, clearance and toxicity. Conclusion:Pharmacologic cardioversion provides a reasonable alternative to electrical cardioversion in many cases.
No takes yet. Share an insight, caveat, or question.
EN et al. (2017) conducted a review in Cardiac arrhythmias. Antiarrhythmic medications was evaluated on Conversion to sinus rhythm. Class IA, IC, and III antiarrhythmic medications effectively convert supraventricular arrhythmias to sinus rhythm, with conversion rates frequently greater than 50%.
Synapse has enriched 10 related papers. Consider them for comparative context: